News

Bandage, tape remain stable

BY Michael Johnsen

The first-aid tape and bandage business is a relatively stable category without a lot of dramatic sales swings. For the 52 weeks ended April 20, sales of first-aid tape and bandages were up 1.3% to $772.5 million across total U.S. multi-outlets, according to IRI. Johnson & Johnson, principally with its Band Aid brand, drives the category with $339.1 million in sales (up 1.1%), followed by 3M and its Curad brand with vendor sales of $70.3 million (0% growth). Sandwiched between the two first-aid giants is private label, which generated $256.8 million in sales (up 5.3%).

There is a company that’s come onto the scene in the past two years looking to drive some foot traffic into the first-aid set that goes beyond buying bandages and tape for minor cuts and scrapes. KT Health, with its KT Tape, is attempting to recreate the Breathe Right phenomena with endorsements by such Olympic athletes as three-time gold medalist and champion volleyball player Kerri Walsh. Breathe Right, a product that opens the nasal passages, became a success after San Francisco 49er’s Jerry Rice wore the nasal strip during a football game in the late 1990s.

KT Health most recently announced it was the official Kinesiology Tape of USA Soccer. “It is an aspirational brand,” John MacKay, KT Health president, told Drug Store News, explaining why athlete endorsements were important. “But it’s applicable for the person who develops tendinitis [from] painting their house … [who finds that when] they throw a strip of tape on, there is an immediate pain-relieving effect and therapeutic effect that gives them accelerated recovery.”

“It treats such a variety of conditions that the challenge then is to educate people on the multiple applications and how to use it. … We have 50 instructional videos on our website,” MacKay said.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Segment sales spike for summer

BY Michael Johnsen

The same weather factors that are boosting allergy sales as the allergy season is extended may be having a substantial impact on the sales of anti-itch ointments, up 10% to $528.2 million across U.S. multi-outlets for the 52 weeks ended April 20, according to IRI, and insect bite treatments, which totaled $13.6 million and were up 19.4% over the same period.

(For the complete category review, including data, click here.)

“We’ve found that poison ivy is greatly affected by weather patterns. Over the last couple of years, spring has been late, cold and wet,” said Lisa Leverich, director marketing at Tec Laboratories. “A wet spring makes for a later, [more lush] poison ivy season. However, July is usually the peak month for poison ivy.”

Rising temperatures and an increase in rainfall throughout much of the country also help boost mosquito and tick populations, according to the National Pest Management Association.

Another factor driving anti-itch is the CrossFit trend, Leverich added. “With the CrossFit trend exploding across the country, people are getting down and dirty in the elements. Warrior and mudder competitions also are hot beds for brushing up against poison ivy.”

Weather has less of an impact on other first-aid categories, such as accessories and bandages, though summertime does see a sales spike in these categories as more and more people venture into the outdoors. And though sales of actual first-aid kits were down 4.6% to $47.2 million across U.S. multi-outlets for the 52 weeks ended April 20, such first-aid kit marketers as Johnson & Johnson have identified an opportunity to build incremental sales through its concept “Build Your Own First Aid Kit,” whereby consumers fill a first-aid kit with J&J branded first-aid merchandise. The concept first was introduced through Target in 2009, but it has expanded to other retailers after successfully increasing the first-aid market basket size.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Lubricants, Plan B boost sales

BY Michael Johnsen

Overall, the intimacy health category generated more than $870 million in sales, trending up in the low single-digits. Sales of condoms, the largest piece of the business, totaled $380.7 million across total U.S. multi-outlets for the 52 weeks ended April 20, and was down slightly by 1.8%. The growth is coming out of the personal lubricant ($213.4 million, up 2.9%) and emergency contraceptive ($253.2 million, up 12.3%) sectors.

(For the complete category review, including data, click here.)

Church & Dwight last year introduced the Trojan brand name to the personal lubricant space with Crazy Sexy Feel. Overall, C&D lubricants generated $18.5 million in sales, ranking the relative newcomer the third-largest personal lubricant brand manufacturer with a dollar share of 8.7%. And though overall sales of Johnson & Johnson lubricants were down 26.4% to $82 million, that lubricant franchise is about to get a fresh makeover as Reckitt Benckiser incorporates its newly bought KY brand into its Durex portfolio.

Niche marketer Lil’ Drug Store Products has carved out profitability in the personal lubricant space by targeting couples trying to conceive. Sales of its PreSeed lubricant were up 26.8% to $3.6 million. And the company is currently launching Replens Silky Smooth — targeting baby boomer women — to meet a demand for post-menopausal intimacy. “Research showed that 78% of Replens Moisturizer users also were using a lubricant, but many water-based lubricants tend to dry out and need to be reapplied during intimacy,” said Doug Marquardt, director of marketing for Replens. “To better enhance intimacy, Replens Silky Smooth was developed to last longer than most leading lubricants. Since Replens Silky Smooth is a premium silicone lubricant, it only needs to be applied once.”

Within the emergency contraceptive sector, the Food and Drug Administration recently ruled that generic equivalents to Teva Pharmaceutical’s Plan B emergency contraceptive can be sold alongside Plan B without any behind-the-counter merchandising restrictions or a requirement to verify the age of the purchaser. In the past year, Gavis Pharmaceuticals launched its My Way emergency contraceptive, and has thus far generated $8.1 million in sales. That has yet to make a dent into Plan B, however. Overall Plan B sales totaled $138 million, up 44.5%.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES